Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients

PHASE4RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 21, 2023

Primary Completion Date

November 30, 2026

Study Completion Date

February 28, 2027

Conditions

Crohn Disease

Interventions

DRUG

Infliximab

Infliximab in the treatment of Crohn's disease in children

Trial Locations (1)

RECRUITING

Beijing Children's Hospital, Capital Medical University, Beijing

All Listed Sponsors

lead

Taizhou Mabtech Pharmaceutical Co.,Ltd

INDUSTRY